Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Human Vaccines & Immunotherapeutics|April 16, 2015
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptideValentina Finessi, Francesco Nicoli, Eleonora Gallerani, et al.
Vaccine|January 13, 2006
Efficient systemic and mucosal responses against the HIV-1 Tat protein by prime/boost vaccination using the lipopeptide MALP-2 as adjuvantStefan Borsutzky, Thomas Ebensen, Claudia Link, et al.
AIDS (London, England)|May 21, 2014
HIV-1 Tat affects the programming and functionality of human CD8⁺ T cells by modulating the expression of T-box transcription factorsFabio Sforza, Francesco Nicoli, Eleonora Gallerani, et al.
Vaccine|March 23, 2016
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infectionFrancesco Nicoli, Eleonora Gallerani, Charalampos Skarlis, et al.
Microbes and Infection|October 26, 2005
Vaccines based on the native HIV Tat protein and on the combination of Tat and the structural HIV protein variant DeltaV2 EnvBarbara Ensoli, Aurelio Cafaro, Antonella Caputo, et al.
Vaccine|August 19, 2003
Mucosal delivery of the human immunodeficiency virus-1 Tat protein in mice elicits systemic neutralizing antibodies, cytotoxic T lymphocytes and mucosal IgAMariarosaria Marinaro, Antonella Riccomi, Rino Rappuoli, et al.
AIDS (London, England)|December 28, 2017
The HIV-1 Tat protein affects human CD4+ T-cell programing and activation, and favors the differentiation of naïve CD4+ T cellsFrancesco Nicoli, Eleonora Gallerani, Fabio Sforza, et al.
Vaccine|February 5, 2008
Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxinAntonella Caputo, Egidio Brocca-Cofano, Arianna Castaldello, et al.
Archives of Virology|August 14, 2021
New insights into pathogenesis point to HIV-1 Tat as a key vaccine targetBarbara Ensoli, Sonia Moretti, Alessandra Borsetti, et al.
The Biochemical Journal|March 4, 2006
Intracellular HIV-1 Tat protein represses constitutive LMP2 transcription increasing proteasome activity by interfering with the binding of IRF-1 to STAT1Anna L Remoli, Giulia Marsili, Edvige Perrotti, et al.
Pageof 7